Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions highlight agreement with the review's findings, mentioning the importance of dose adjustment for atrial fibrillation and cautioning against its use for VTE treatment; for example, users discuss the relevance of low-intensity treatment and references to specific trials, using language that indicates they see this review as significant for future clinical decisions.
Most discussions emphasize the importance of dose adjustment strategies and agree with the review's conclusions, reflecting consensus in the community.
The discussions display a high level of attention to the topic, with numerous posts discussing specifics about dose-reduction methods and their implications.
Many users reference the article directly, quoting or summarizing key points, indicating active engagement but not deep original analysis.
The widespread sharing and validation suggest the review influences practices and perceptions around anticoagulant dosing, though some notes about ongoing research temper the perceived immediate impact.
Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review https://t.co/Dm1xmIbP3W
This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolism (VTE). Dose-adjustment is relevant for AF and shouldn't be used for VTE. Low-intensity tx may be used for VTE prevention. @bbikdeli https://t.co/A7ZuahGmwH
This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolism (VTE). Dose-adjustment is relevant for AF and shouldn't be used for VTE. Low-intensity tx may be used for VTE prevention. @bbikdeli https://t.co/TK9BhPE5dE
Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for primary or secondary VTE prevention Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review https://t.co/Dm1xmIbP3W
BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMACardio @JAMANetwork @fikkumamoto @vic_pallares @Medtorek @chemachir @QuirosLopezRaul @mendez_bailon @drmiguelmarcos @roca_ferran @DrMarthaGulati @GiuseppeGalati_
This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolism (VTE). Dose-adjustment is relevant for AF and shouldn't be used for VTE. Low-intensity tx may be used for VTE prevention. @bbikdeli https://t.co/rCkTvaNG2h
Prof. Bikdeli and Prof. Didier discuss the HIPRO study on extended treatment of provoked venous thromboembolism, presented at the 2025 European Society of Cardiology meeting. The study compares rivaroxaban monotherapy…
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/CdeLOZFq2Q vía @JAMACardio part of @JAMANetwork
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolism (VTE). Dose-adjustment is relevant for AF and shouldn't be used for VTE. Low-intensity tx may be used for VTE prevention. @bbikdeli https://t.co/TK9BhPE5dE
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @bbikdeli: Our @JAMACardio review of dose-⬇️DOACs #apixaban #rivaroxaban #edoxaban #dabigatran 1. Low-intensity is ≠ dose-adjusted
RT @bbikdeli: Our @JAMACardio review of dose-⬇️DOACs #apixaban #rivaroxaban #edoxaban #dabigatran 1. Low-intensity is ≠ dose-adjusted
RT @bbikdeli: Our @JAMACardio review of dose-⬇️DOACs #apixaban #rivaroxaban #edoxaban #dabigatran 1. Low-intensity is ≠ dose-adjusted
Our @JAMACardio review of dose-⬇️DOACs #apixaban #rivaroxaban #edoxaban #dabigatran 1. Low-intensity is ≠ dose-adjusted
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolism (VTE). Dose-adjustment is relevant for AF and shouldn't be used for VTE. Low-intensity tx may be used for VTE prevention. @bbikdeli https://t.co/A7ZuahGmwH
RT @CordobaETV: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/1engz2WxO4 vía @JAMACardio p…
RT @SABOURETCardio: Efficacy and Safety Considerations With Dose-Reduced #DOAC look at the conclusion https://t.co/bAuFq0DqWu
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
Efficacy and Safety Considerations With Dose-Reduced #DOAC look at the conclusion https://t.co/bAuFq0DqWu
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @CordobaETV: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/1engz2WxO4 vía @JAMACardio p…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @CordobaETV: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/1engz2WxO4 vía @JAMACardio p…
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/1engz2WxO4 vía @JAMACardio part of @JAMANetwork
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
Dose adjustment and low-intensity treatment are 2 different forms of dose-reduced #DOACs. Dose adjustment is mostly relevant for #AF and should be done based on the approved criteria. https://t.co/CRerDt7x4V
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
RT @mmonrealriete: Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy a…
Low-intensity DOACs may be used for primary or secondary VTE prevention for studied and approved indications Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review https://t.co/Dm1xmIbP3W
RT @TaniaAhuja:
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @LiverpoolCCS: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review | Venous Thromboembolism | JAMA…
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/CvINcGTDXS a través de @JAMACardio part of @JAMANetwork
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @pinacol: 【総説】減量したDOACの有効性と安全性 #ペ読 https://t.co/1JuR2L4qS0
@gunnar_heine Thx so much! Great comment. Many❓about pts w advanced renal dysfunction & ESRD. #RENAF_AF❌, #VALKYRIE was interesting but not large enough. Regulatory bodies made recs based on not-so-strong data...My hope is more RCTs in the next Ys. Some in Appendix. https://t.co/LVhyAwUhZK
RT @LiverpoolCCS: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review | Venous Thromboembolism | JAMA…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review | Venous Thromboembolism | JAMA Cardiology | JAMA Network @LHCHFT @LivHPartners @LJMU_Health https://t.co/udlwz7lIdG https://t.co/N6PSUqmxFs
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @Manugrillo2: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants #DOACS https://t.co/cdgv8HsOq1 vía @JAMACa…
RT @DrDeLasSalasGER: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review | Venous Thromboembolism | J…
Great work @bbikdeli @farbod_ZT @psadeghipour @AzitaTalasaz @DebSiegal @mmonrealriete @DJC6998 @connors_md @GBarnesMD @sahilparikhmd @ajaykirtane @RenatoDLopes1 @DLBHATTMD @IsthPresident @Drroxmehran @hmkyale https://t.co/X7VUK8cxi4 #DOACs #VTE #AF
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review | Venous Thromboembolism | JAMA Cardiology | JAMA Network https://t.co/PUYA89BsTh
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants #DOACS https://t.co/cdgv8HsOq1 vía @JAMACardio part of @JAMANetwork
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
RT @mmonrealriete: Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for prima…
Dose adjustment of DOACs should not be used for acute VTE therapy In contrast, low-intensity DOACs may be used for primary or secondary VTE prevention Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review https://t.co/Dm1xmIbP3W
RT @TaniaAhuja:
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
RT @JAMACardio: This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolis…
This review evaluates dose-reduced direct oral anticoagulants (DOAC) for atrial fibrillation (AF) and venous thromboembolism (VTE). Dose-adjustment is relevant for AF and shouldn't be used for VTE. Low-intensity tx may be used for VTE prevention. @bbikdeli https://t.co/rCkTvaNG2h
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @bbikdeli: @luistrombo Thanks so much! Here it is: https://t.co/LVhyAxbSRi
RT @TaniaAhuja:
RT @bbikdeli: @luistrombo Thanks so much! Here it is: https://t.co/LVhyAxbSRi
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @SeguraCardio:
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @fikkumamoto: Jama cardiology - Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/zH76fPkfuQ…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @SeguraCardio:
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
RT @FormigaFrancesc: BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMAC…
BASIC: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/38BkS58com @JAMACardio @JAMANetwork @fikkumamoto @vic_pallares @Medtorek @chemachir @QuirosLopezRaul @mendez_bailon @drmiguelmarcos @roca_ferran @DrMarthaGulati @GiuseppeGalati_
RT @DrDeLasSalasGER: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review | Venous Thromboembolism | J…
RT @DrDeLasSalasGER: Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review | Venous Thromboembolism | J…
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review | Venous Thromboembolism | JAMA Cardiology | JAMA Network https://t.co/nF3W3w7oFw
Jama cardiology - Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants https://t.co/zH76fPkfuQ via @JAMACardio part of @JAMANetwork
@luistrombo Thanks so much! Here it is: https://t.co/LVhyAxbSRi
doi:10.1001/jamacardio.2022.1292 2. Công ty Bayer AG (2019), "Tờ thông tin sản phẩm Xarelto 15mg, 20mg” 3. Công ty Bayer AG (2017), "Tờ thông tin sản phẩm ...
MM
JC
FF
D
K
Cባ
AP
DJ
DK
GR
LS
DK
EB
JB
MK
AH
MF
BB
DP
AR
AB
JC
AH
RC
EJ
S
SA
EE
R
CF
GZ
LP
DV
ÁS
JQ
MA
GP
GR
C
MS
TI
A
CH
EL
DV
LP
IP
B
SM
LL
DS
GD
MG
CP
JR
GB
JA
GP
AF
AL
LN
DP
MP
IM
NV
XH
J
DJ
MM
AZ
MG
DR
M
PT
MM
FR
A
JA
IK
TA